Schroder ISF Healthcare Innovation has a history going back to 2020. The management company, Schroders, is an active asset manager covering equities, fixed income and private markets, with roots back to 1804 and headquarters in London. The company has been 100% controlled by Nuveen, part of the TIAA group, since the acquisition on 1 October 2026.
Investment philosophy
The fund invests in health care and medical-related companies worldwide that meet the manager's sustainability criteria. Its reference is a broad global equity index, not a health care index.
The managers
The fund is managed by one person, John Bowler in London. He is a global sector specialist for health care at Schroders, which he joined in 2003, and is listed as manager since 2019. He previously worked in healthcare research at AXA Investment Managers and at State Street Research. He holds a PhD in biochemistry and physiology from the University of Manchester.
The portfolio
The portfolio has more positions than comparable funds and has been less volatile. The lasting top positions are large pharmaceutical and health care companies such as Johnson & Johnson, AstraZeneca, Eli Lilly and UnitedHealth Group.
FundTelligence description · 18/10/2026
Comparison basis: Ranked among 18 of 31 funds · 13 left out (5 share class outside the rule, 3 missing return, 1 return as of an earlier date, 1 history too short, 3 return without a stated date) · returns as of 12 Nov 2026–13 Nov 2026
Portfolio managers
JO
Portfolio Manager
On the fund since Jul 31, 2019
Position in the peer group
Sector Health Care Equities · 31 funds in the peer group. The number ranked and the date are stated per period. 12 of them converted to NOK.
7 of 18 funds ranked on a calculated return
#13/ 18Year to date
+3.98% NOK
From NAV as of 16 Nov 2026
as of 13 Nov 2026 · Converted from USD to NOK
About the figures
13 of 31 funds in the group hold no figure for the date and are not counted. 1 funds with older figures: up to 5 business days.
#16/ 221 year
+8.23% NOK
From NAV as of 16 Nov 2026
as of 13 Nov 2026 · Converted from USD to NOK
About the figures
9 of 31 funds in the group hold no figure for the date and are not counted. 1 funds with older figures: up to 5 business days.
#16/ 223 years (ann.)
+5.76% NOK
From NAV as of 16 Nov 2026
as of 13 Nov 2026 · Converted from USD to NOK
About the figures
9 of 31 funds in the group hold no figure for the date and are not counted. 1 funds with older figures: up to 5 business days.
#17/ 225 years (ann.)
+3.73% NOK
From NAV as of 16 Nov 2026
as of 13 Nov 2026 · Converted from USD to NOK
About the figures
9 of 31 funds in the group hold no figure for the date and are not counted. 1 funds with older figures: up to 5 business days.
Comparison basis
Year to date
Comparison basis: Ranked among 18 of 31 funds · 13 left out (5 share class outside the rule, 3 missing return, 1 return as of an earlier date, 1 history too short, 3 return without a stated date) · returns as of 12 Nov 2026–13 Nov 2026
1 year
Comparison basis: Ranked among 22 of 31 funds · 9 left out (4 missing return, 2 return as of an earlier date, 3 return without a stated date) · returns as of 12 Nov 2026–13 Nov 2026
3 years (ann.)
Comparison basis: Ranked among 22 of 31 funds · 9 left out (4 missing return, 2 return as of an earlier date, 3 return without a stated date) · returns as of 12 Nov 2026–13 Nov 2026
5 years (ann.)
Comparison basis: Ranked among 22 of 31 funds · 9 left out (4 missing return, 2 return as of an earlier date, 3 return without a stated date) · returns as of 12 Nov 2026–13 Nov 2026
The positions describe historical return and are not an assessment of the fund, nor investment advice. Past performance is no guarantee of future returns. A position applies only within its own peer group and cannot be compared with positions in other peer groups.
Fund data is taken from the managers’ own reports, otherwise computed from NAV history and, as a last resort, taken from distributor listings. Not official figures; verify with the fund provider before investing.